Interleukin-22 Polymorphisms in Plasmodium falciparum-Infected Malaria Patients

Mediators Inflamm. 2020 Feb 19:2020:5193723. doi: 10.1155/2020/5193723. eCollection 2020.

Abstract

Background and Objectives. Malaria infection, caused by Plasmodium falciparum, is the most lethal and frequently culminates in severe clinical complications. Interleukin-22 (IL-22) has been implicated in several diseases including malaria. The objective of this study was to investigate the role of IL-22 gene polymorphisms in P. falciparum infection. Material and Methods. Ten single-nucleotide polymorphisms (SNPs), rs976748, rs1179246, rs2046068, rs1182844, rs2227508, rs2227513, rs2227478, rs2227481, rs2227491, and rs2227483, of IL-22 gene were genotyped through PCR-based assays of 250 P. falciparum infection. IL-22 gene promoter activity.

Results: We found that the rs2227481 TT genotype (odds ratio 0.254, confidence interval = 0.097-0.663, P. P. falciparum infection. P. P. P. P.

Conclusion: The study suggests that IL-22 polymorphisms in rs2227481 and rs2227483 could contribute to protection against P. falciparum infection. IL-22 gene promoter activity.

MeSH terms

  • Confidence Intervals
  • Gene Frequency / genetics
  • Genetic Predisposition to Disease / genetics
  • Genotype
  • Haplotypes / genetics
  • Humans
  • Interleukin-22
  • Interleukins / genetics*
  • Malaria / genetics*
  • Odds Ratio
  • Plasmodium falciparum / pathogenicity
  • Polymorphism, Single Nucleotide / genetics*
  • Promoter Regions, Genetic / genetics

Substances

  • Interleukins